India is a vaccine-manufacturing hub and our strategic partner for production of Sputnik V. RDIF has created partnerships with a number of India’s leading pharmaceutical companies for production of Sputnik V which will provide for both vaccination of the population in India and global distribution ...
The DCGI granted permission to SII to produce the Sputnik V vaccine in India. Credit: IMF Photo / Sergey Ponomarev / Flickr. The Drug Controller General of India (DCGI) has granted approval to the Serum Institute of India (SII) to produce Russia’s Covid-19 vaccine, Sputnik V, in the...
We are pleased to partner with RDIF to bring the vaccine to India. The Phase I and II results have shown promise, and we will be conducting Phase-III trials in India to meet the requirements of the Indian regulators. Sputnik V vaccine could provide a credible option in our fight against ...
Sputnik V will be the third COVID-19 vaccine in India after Covaxin and Covishield. The vaccine comes at a time when the second wave of COVID-19 has wreaked havoc in India and daily new cases are making new records with each passing day. Federal health ministry Saturday morning said 401,...
Sputnik V will be the third COVID-19 vaccine in India after Covaxin and Covishield. The vaccine comes at a time when the second wave of COVID-19 has wreaked havoc in India and daily new cases are making new records with each passing day. ...
He underscored that, considering the recent beginning of vaccination with the Russian vaccine in India, this second shipment was timely. "The Sputnik V’s efficiency is well known in the world. The vaccine is successfully being used for vaccination of the people in Russia since second half of ...
The Drug Controller General of India has permitted Serum Institute of India to manufacture the Sputnik V vaccine in India with certain conditions, official sources said on Friday. Comments
With the Sputnik V vaccine’s recent approval, India now has three vaccines authorized for COVID-19 treatment. However, despite better efficacy overSerum Institute of India/ AstraZeneca’sCovishield andBharat Biotech’sCovaxin, Sputnik V will face stiff competiti...
Dr Reddy’s initiated a limited pilot soft launch of the Sputnik V vaccine in Hyderabad on May 14. The ongoing pilot has been scaled up to over 27 cities across India ahead of the commercial launch. Samit Jain, CEO, PLUSS said, “It is a privilege to be a part of Dr Reddy’s effo...
animals United Kingdom (UK) More 'I Dreamt to Be Professional Cricketer': Polio-Afflicted Scientist Shares His Ordeal Aneela Rashid 9 November 2022, 16:20 GMT disease World polio health Interviews vaccine Asia Pakistan More1 20 more articles...